Size dependence of nanoparticle-protein interaction and high sensitivity potentiometric sensor exploiting such interactions
10370694 ยท 2019-08-06
Assignee
Inventors
Cpc classification
C25D5/18
CHEMISTRY; METALLURGY
B82Y30/00
PERFORMING OPERATIONS; TRANSPORTING
G01N27/3278
PHYSICS
G01N2333/904
PHYSICS
International classification
G01N27/327
PHYSICS
C25D5/18
CHEMISTRY; METALLURGY
C12Q1/00
CHEMISTRY; METALLURGY
Abstract
Fabrication of a high sensitivity potentiometric biosensor is described. The present inventors have developed and characterized a novel amplification platform using a gold nanoparticle (GNPs) electrodeposition method. The synthesized GNP sizes were found to be dependent of HAuCl.sub.4 concentration, media acid, scan cycles and scan rate. A systematic investigation into the adsorption of different sizes of proteins from aqueous electrolyte solution onto the electrodeposited GNPs surface by the potentiometric method was performed. Results suggest that the size of different proteins affect how they bond to different sizes of GNPs. This GNPs-based biosensor can retain the native-like structure of proteins, and successfully detect proteins at a high sensitivity level. The resulting glucose and immune biosensors also exhibit low detection limit and wide linear range. This improvement to potentiometric devices enables them to serve as highly sensitive detectors for biomolecules and provides a model that can be used to predict protein bonding on nanoparticles.
Claims
1. A method for making a potentiometric biosensor including a specific protein adsorbed onto gold nanoparticles, the method comprising: a) electrodepositing gold onto an electrode to produce a gold nanoparticle modified electrode, wherein the electrodepositing uses electrodeposition parameters selected to deposit gold nanoparticles on the electrode such that a mean size of the deposited gold nanoparticles corresponds to a size promoting, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, adsorption of the specific protein onto the gold nanoparticles; and b) adsorbing the specific protein onto the gold nanoparticle electrode to produce the potentiometric biosensor, wherein the specific protein selected from a group consisting of (A) Bovine serum albumin (BSA), (B) glucose oxidase (GOx), and (C) Casein, and wherein if the specific protein is BSA, then the mean size of the deposited gold nanoparticles is 5 nm2 nm, if the specific protein is GOx, then the mean size of the deposited gold nanoparticles is 14 nm2 nm, and if the specific protein is Casein, then the mean size of the deposited gold nanoparticles is 40 nm2 nm.
2. The method of claim 1 wherein the act of electrodepositing is performed using cyclic voltemmetry electrodeposition.
3. The method of claim 2 wherein at least one of the electrodepostion parameters is a voltage scan rate.
4. The method of claim 2 wherein at least one of the electrodepostion parameters is a maximum number of scan cycles.
5. The method of claim 1 wherein the electrodepositing uses electrodeposition parameters selected to deposit gold nanoparticles on the electrode such that a mean size of the deposited gold nanoparticles corresponds to a size optimizing, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, adsorption of the specific protein onto the gold nanoparticles.
6. A method for making a potentiometric biosensor including a specific protein adsorbed onto gold nanoparticles, the method comprising: a) electrodepositing gold onto an electrode to produce a gold nanoparticle modified electrode, wherein the electrodepositing uses electrodeposition parameters selected to deposit gold nanoparticles on the electrode such that a mean size of the deposited gold nanoparticles corresponds to a size promoting, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, adsorption of the specific protein onto the gold nanoparticles; and b) adsorbing the specific protein onto the gold nanoparticle electrode to produce the potentiometric biosensor, wherein the act of electrodepositing is performed using cyclic voltemmetry electrodeposition, and wherein at least one of the electrodepostion parameters is acidic solution concentration.
7. A potentiometric biosensor comprising: a) an electrode; b) gold nanoparticles coating a surface of the electrode; and c) a specific protein adsorbed onto the gold nanoparticles, wherein a mean size of the gold nanoparticles is one that promoted, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, the adsorption of the specific proteins, wherein the specific protein selected from a group consisting of (A) Bovine serum albumin (BSA), (B) glucose oxidase (GOx), and (C) Casein, and wherein if the specific protein is BSA, then the mean size of the deposited gold nanoparticles is 5 nm2 nm, if the specific protein is GOx, then the mean size of the deposited gold nanoparticles is 14 nm2 nm, and if the specific protein is Casein, then the mean size of the deposited gold nanoparticles is 40 nm2 nm.
8. The potentiometric biosensor of claim 7 wherein the specific protein remains active after its adsorption onto the gold nanoparticles.
9. The potentiometric biosensor of claim 7 wherein the specific protein is not denatured by its adsorption onto the gold nanoparticles.
10. The potentiometric biosensor of claim 7 wherein a mean size of the gold nanoparticles is one that optimized, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, the adsorption of the specific proteins.
Description
3 BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
4 DETAILED DESCRIPTION
(7) Example embodiments consistent with the present invention may involve novel methods, apparatus, and compositions of matter for potentiometric biosensing, and methods for making potentiometric biosensors. The following description is presented to enable one skilled in the art to make and use the invention, and is provided in the context of particular applications and their requirements. Thus, the following description of embodiments consistent with the present invention provides illustration and description, but is not intended to be exhaustive or to limit the present invention to the precise form disclosed. Various modifications to the disclosed embodiments will be apparent to those skilled in the art, and the general principles set forth below may be applied to other embodiments and applications. For example, although a series of acts may be described with reference to a flow diagram, the order of acts may differ in other implementations when the performance of one act is not dependent on the completion of another act. Further, non-dependent acts may be performed in parallel. No element, act or instruction used in the description should be construed as critical or essential to the present invention unless explicitly described as such. Also, as used herein, the article a is intended to include one or more items. Where only one item is intended, the term one or similar language is used. Thus, the present invention is not intended to be limited to the embodiments shown and the inventors regard their invention as any patentable subject matter described.
4.1 EXAMPLE EXPERIMENTS
(8) The following experiments test a new platform for high sensitivity potentiometric sensing. GNPs with different sizes were directly electrodeposited onto glassy carbon (GC) and indium tin oxide (ITO) film coated glass electrodes. The surfaces of the modified electrodes were characterized using Atomic Force Microscopy (AFM). The application of GNPs of different sizes modified electrodes were investigated for the potentiometric detection of different proteins.
4.1.1 Materials and Methods Used in Example Experiments
4.1.1.1 Materials
(9) Gold (III) chloride trihydrate 99.9%, BSA, anti-BSA produced in rabbit, GOx, and casein were purchased from Sigma-Aldrich and used without further purification. All solutions were prepared in Milli-Q water (18 M). A pH 7.4 phosphate-buffered saline (PBS) solution of 0.2 M disodium orthophosphate (Na.sub.2HPO.sub.4), 0.2 M sodium dihydrogen orthophosphate (NaH.sub.2PO.sub.4) was prepared. Before use, the PBS solution was diluted to 10 mM with Milli-Q water. This PBS solution was used as electrolyte solution for potentiometric detection, and to prepare various protein solutions, which were stored at 4 C. while not in use.
4.1.1.2 Methods: Electrodeposition of GNPs
(10) The fabrication of GNPs on a GC (3 mm dia., CH Instrument) or ITO (15-25 ohms, Delta Technologies, LTD) electrode was performed using electrochemical deposition. (See, e.g., the articles, Wang, Y., et al., Electrodeposition of Large Size Gold Nanoparticles on Indium Tin Oxide Glass and Application as Refractive Index Sensor, Electrochemistry Communications, 2009. 11(5): p. 1034-1037 and Zhao, Y., et al., Electrocatalytic Behavior and Amperometric Detection of Morphine on ITO Electrode Modified with Directly Electrode posited Gold Nanoparticles, Electroanalysis, 2009. 21(8): p. 939-943 (incorporated herein by reference).) A GC electrode was polished with aluminum oxide powder and electrochemically treated in 1 M H.sub.2SO.sub.4 solution to remove any organic binders and contamination that occurs at electrode surface. An ITO electrode was sequentially sonicated in acetone, ethanol, and distilled water (DI water) for 15 min. After cleaning, the GC or ITO electrode was immersed into the solution of HAuCl.sub.4 in H.sub.2SO.sub.4. A cyclic voltammetric mode with the potential range of 1 V to 1 V was performed for electrodeposition. (See Results and Discussion in 4.1.2 for details.) Then the electrode was quickly removed, washed with DI water and dried with a stream of nitrogen. The electrochemical experiments were performed by a CHI 660D electrochemical workstation (CH Instruments, Inc.) with a conventional three electrode system, including the GC or ITO electrode as working electrode, a Ag/AgCl electrode as the reference electrode and a platinum wire as the counter electrode.
4.1.1.2 Methods: Potentiometric Detection
(11) Potentiometric detection was performed by EMF interface instrument (Malvern, Pa.) for monitoring potential change simultaneously in real time. The GNPs-modified GC working electrode and the Ag/AgCl (1 M KCl) reference electrode were immersed into the PBS solution and the signal of potential change was recorded. After the potential signal was stable (less than 1 mV drift in 10 min), a series concentrations of proteins were added into the solution to check the signal changes.
4.1.1.3 Methods: Atomic Force Microscopy
(12) For imaging GNPs and proteins on the ITO surface, atomic force microscopy (AFM) experiments were performed with a multimode scanning probe microscope equipped with the type EV scanner and Nanoscope IIIa controller (Digital Instruments, Veeco). The tapping mode was employed under ambient air using an etched silicon probe (Bruke AFM probes, spring constant 42 N m.sup.1, drive frequency 320 kHz). Data were recorded at a scan rate of 1-3 Hz, and stored in 256256 pixel format. Images were processed using the Nanoscope version 4.43r8 software (Digital Instruments, Veeco). No processing was used on images obtained in the tapping mode, except for a flattening operation. For images to be used in measuring heights, only zero-order flattening was used. For image presentation, first-order flattening was used unless otherwise indicated.
4.1.1.4 Methods: Glucose Detection to Demonstrate that GOx Remains Active on a GNP Plated Electrode
(13) The detection of glucose was performed in an electrochemical cell filled with 20 mM of 10 mM PBS at room temperature. In a steady-state amperometric experiment, the potential was set at 0.6 V under gentle magnetic stirring.
4.1.2 Experimental Results and Discussion
4.1.2.1 Optimization of Electrodeposition Efficiency
(14) Electrodeposition of GNPs is a fast and convenient method of preparation. Various electrochemical methods, such as potential step, pulse techniques and cyclic voltammetry (CV) have been used for electrodeposition of GNPs. Here, the electrodeposition of GNPs on a GC electrode was been performed in H.sub.2SO.sub.4 acidic solution containing HAuCL.sub.4 by the cyclic voltammetry method.
(15) As seen, on the cathodicgoing scan, the cathodic peak appeared at around 0.4 V and is due to reduction of gold (III) to gold. In the second cycle, this peak shifted to more positive potential. This indicates easier electrodeposition of gold on the existing gold particles. With scanning to more negative potentials, a sharp increase in reduction current at potential more negative than 0.5 V is attributed to the reduction of water, resulting in the formation of hydrogen gas. (See, e.g., the article, Moulton, S. E., et al., Investigation of Protein Adsorption and Electrochemical Behavior at a Gold Electrode, Journal of Colloid and Interface Science 2003. 261(2): p. 312-319 (incorporated herein by reference).) On the anodicgoing scan, the peak at 1 V corresponds to the surface oxidation of the electro deposited gold. Our SEM and UV-vis spectrum results also confirmed that the GNPs were successfully deposited onto the surface of electrode with a quite symmetric distribution.
(16) From the foregoing results, the present inventors found the electrodeposition of GNPs with different potential ranges exhibit different potentials of gold reduction peak, which move toward to a more negative potential gradually along with extending of the potential range from 10 V to 10.4 V, 10.5 V and 11 V. (See
4.1.2.2 Optimal Conditions for Protein Adsorption
(17) For the mechanism of GNPs electrodeposition, it was confirmed that free gold (III) ions from solution will become attached to the surface of the electrode via electrostatic interaction first. Then, the application of potential to the electrode promoted the subsequent reduction of gold (III) ion. (See e.g., the article, Mohanty, U.S., Electrodeposition: A Versatile and Inexpensive Tool for the Synthesis of Nanoparticles, Nanorods, Nanowires, and Nanoclusters of Metals, Journal of Applied Electrochemistry, 2011 41(3): p. 257-270 (incorporated herein by reference).) The size and quantity of GNPs electrodeposited on the electrode surface depends on the gold (III) ion adsorbance and deposition time. The concentration of HAuCl.sub.4, acidity of solution media, scan cycles and scan rate also have an effect on the size and film thickness of GNPs deposited. Here, the present inventors electrodeposited GNPs films on electrodes by cyclic voltammetry, and controlled the growth of nanoparticles size and film thickness with these different parameters. The present inventors chose three kinds of proteins, casein, GOx and BSA, which have different molecular weight but the similar value of pI. As all the pI's of BSA, GOx and casein are around 4.5, these proteins were negative charges in PBS buffer (pH 7.4). In this part, GNPs were electrodeposited with the different concentrations of HAuCl.sub.4, acidic solution media, cycles and scan rates. The potentiometric method was used to evaluate the ability of the proteins to be immobilized on the surface of GNPs. The experiments by the present inventors found under which parameters the synthesized GNPs can adsorb proteins effectively.
(18)
(19) In the following, the present inventors also detected the GOx and casein adsorption efficiency with different sizes and densities of GNPs. The present inventors found that the maximum of GOx bonding on GNPs was observed when GNPs was electrodeposited in the solution containing 1 mM HAuCl.sub.4 (See
(20) The foregoing results indicate that different sizes of proteins have different adsorption ability with GNPs.
4.1.2.3 Atomic Force Microscopy (AFM) Results
(21) The morphologies of the modified electrodes were investigated using AFM. For the convenience of AFM operation, GNPs were electrodeposited on the ITO electrodes with methods 1, 2 and 3, described above.
(22)
4.1.2.4 Potentiometric Detection
(23) It is well known that there are three (3) mechanisms to explain the adsorption of protein to GNPs, namely: (1) electrostatic interaction of GNPs and opposite charged proteins; (2) covalent bonding between the thiols/amine group present within the amino acids in the protein and GNPs; and (3) hydrophobic interaction between proteins and GNPs. Global electrostatic effects may dominate when the protein is structurally stable and the solid surface is hydrophilic. (See, e.g., the article, Karnik, R., K. Castelino, and A. Majumdar, Field-Effect Control of Protein Transport in a Nanofluidic Transistor Circuit, Applied Physics Letters, 2006 88(12) (incorporated herein by reference).) As BSA, GOx and casein are negatively charged in the neutral PBS buffer (pH 7.4), the difference of electrostatic interactions between proteins and GNPs can be neglected given their similar pI values (that is, 4.2, 4.6 and 4.8).
(24) To verify the signal amplification by GNPs, the present inventors compared the potentiometric response of these three kinds of proteins adsorption on both (1) GC electrodes and (2) GNPs-modified GC electrodes. In
(25) Referring to plots A-C of
4.1.2.5 Surface Activity of Proteins on GNPs Surface
(26) Proteins are highly surface active and they interact with solid-liquid interfaces mainly through three subprocesses, namely: (1) structural rearrangement in the protein molecule; (2) dehydration of parts of protein and surface hydrophobic effect; and (3) redistribution charged group in the interfacial layer. (See, e.g., the article, Karnik, R., K. Castelino, and A. Majumdar, Field-Effect Control of Protein Transport in a Nanofluidic Transistor Circuit, Applied Physics Letters, 2006 88(12) (incorporated herein by reference).) If proteins bond to the solid surface, most of proteins will undergo denaturation of their tertiary structure, and their secondary structure could also be disrupted in some cases. The present inventors evaluated the activity of BSA and GOx after they were adsorbed on the surfaces of GNPs.
(27)
(28) More specifically,
(29) GOx can catalyze the oxidation of -D-glucose to D-glucono--lactone and hydrogen peroxide which then can be detected by an amperometric method.
(30) As demonstrated in
(31) TABLE-US-00001 TABLE 1 Comparison of potentiometric biosensors for detection of proteins Linear Detection Type of Assay range limit protein principle (nM) (nM) Reference Anti - GNPs 0.007- 0.003 Our result BSA electro- 0.387 depositon on electrode surface Human Func- 0.006- 0.002 (See, e.g., the article, immuno- tionalized 0.08 Li, J. P. and H. D. Gao, globulin Fe3O4 A Renewable G nanoparticles Potentiometric immobilized Immunosensor Based on electrode on Fe3O4 surface Nanoparticles Immobilized Anti-IgG, Electroanalysis, 2008. 20(8): p. 881-887 (incorporated herein by reference).) Hepatitis Enzyme 0.0007 0.0002 (See, e.g., the article, B surface labeled 0.067 Ding, C. F., et al., antigen secondary Electrochemical antibody- Immunoassay of gold Hepatitis B Surface nanoparticles Antigen by the (GNPs) bio- Amplification of Gold conjugates Nanoparticles Based on the Nanoporous Gold Electrode, Talanta, 2010. 80(3): p. 1385-1391 (incorporated herein by reference).) Thrombin SWCNTas 100- 80 (See, e.g., the article, transducers, 1000 Duzgun, A., et al., and aptamers Solid-Contact as bio- Potentiometric recognition Aptasensor Based elements on Aptamer Functionalized Carbon Nanotubes for the Direct Determination of Proteins, Analyst, 2010. 135(5): p. 1037-1041 (incorporated herein by reference).) Mouse GNPs 3- 0.013 (See, e.g., the article, IgG labeled 45 Chumbimuni-Torres, antibody K. Y., et al., for signal Potentiometric amplification Biosensing of Proteins with Ultrasensitive Ion-Selective Microelectrodes and Nanoparticle Labels, Journal of the American Chemical Society, 2006. 128(42): p. 13676- 13677 (incorporated herein by reference).)
4.3 Refinements, Alternative and Extensions
(32) Although the foregoing examples concerned adjusting the average size of gold nanoparticles by properly setting parameters of cyclic voltemmetry electrodeposition, the size of other types of nanoparticles can be adjusted or set using the same or other techniques using the foregoing description and the following guidance. The desired result is to produce a nanoparticle surface in which an average size of the nanoparticles facilitates immobilization of a desired protein on the nanoparticle surface without denaturing the protein such that the protein remains active after it is immobilized. This can be accomplished when one considers the relationship between (1) the size of the protein at the anchoring point(s), and (2) the size and curvature of the nanoparticles. One may also consider how the protein is immobilized on the nanoparticle layer (e.g., by physisorption (e.g., electrostatic, hydrophobic, van der Waals, physical encapsulation or entrapment, and/or hydrogen bonding), bioaffinity interaction, or covalent bonding). In the foregoing examples, the inventors believe the proteins were immobilized on the gold nanoparticles due to covalent bonding, electrostatic forces, and hydrophopic attraction.
(33) Although gold nanoparticles were used in the examples provided above, the present invention extends to other nanoparticles (such as platinum, palladium, copper, metal oxide, etc.). Although conducting nanoparticles should be used in potentiometric biosensors, non-conducting nanoparticles can be used in other types of biosensors.
(34) Although electrodepositing was used in the examples provided above, other techniques for depositing the nanoparticles onto an electrode or other biosensor surface can be used instead.
4.4 CONCLUSION
(35) The present inventors were able to make potentiometric biosensors, each with high sensitivity, by electrodepositing gold nanoparticles (GNPs). The adsorption of three model proteins with different sizesBSA, GOx and caseinon the surfaces of GNPs-modified electrodes were investigated, and the present inventors found that GNP sizes played important role on proteins adsorption. Different sizes of proteins have different bonding with GNPs, which is size dependent. Real-time measurement of antibody adsorption onto the immobilized antigen was also detected using the resulting biosensors. A low detection limit of 3 pM and a linear range from 0.007 nm to 0.387 nM were achieved without a label step typically used in other techniques.